INTC
36
-5
AMP
54
-3
MCO
64
-4
ICE
69
-5
TRIP
37
-7
PDCO
69
-2
SO
66
2
EXPE
70
-2
DVA
59
-4
ISRG
57
-5
SYK
37
-3
UHS
64
-3
LEG
29
-2
COF
58
-2
EBAY
45
-2
EOG
39
-2
WFC
69
-5
WEC
77
2
AON
73
-2
TROW
34
7
INTC
36
-5
AMP
54
-3
MCO
64
-4
ICE
69
-5
TRIP
37
-7
PDCO
69
-2
SO
66
2
EXPE
70
-2
DVA
59
-4
ISRG
57
-5
SYK
37
-3
UHS
64
-3
LEG
29
-2
COF
58
-2
EBAY
45
-2
EOG
39
-2
WFC
69
-5
WEC
77
2
AON
73
-2
TROW
34
7
Financhill
Back

Armata Pharmaceuticals 10K Form

Sell
15

ARMP
Armata Pharmaceuticals

Last Price:
$1.44
Seasonality Move:
1.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $820K
Cash Flow: $-7.9M
Price / Cash Flow: 0
Annual Sales: $-1.33
Price / Book: 0

Profitability

EPS (TTM): -1.32000
Net Income (TTM): $-18.9M
Gross Margin: $410K
Return on Equity: 0%
Return on Assets: 0%

Armata Pharmaceuticals Earnings Forecast

Key Armata Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ARMP is 100.24%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 971.46% of Gross Profit Margin.
  • Per Share Earnings over the last 29 years have been positive in 12 years.

Armata Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Sell
15
Armata Pharmaceuticals (ARMP) is a Sell

Is Armata Pharmaceuticals a Buy or a Sell?